Dr. Joseph J Coyne, PH.D. Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 645 Westwood Ave, Suite 303, Rivervale, NJ 07675 Phone: 201-666-0232 |
Kathryn Capawana, LCSW, LCADC Counselor - Addiction (Substance Use Disorder) Medicare: Accepting Medicare Assignments Practice Location: 645 Westwood Avenue, Suite 204, Rivervale, NJ 07675 Phone: 201-895-6402 |
Helena Fotopoulos, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 184 Rivervale Rd, Rivervale, NJ 07675 Phone: 201-281-1684 |
News Archive
"Each year 1.2 million children under age 5 die from Streptococcus pneumoniae and Haemophilus influenzae B or Hib," which cause pneumococcal disease and are preventable with vaccines, according to studies published Thursday in the journal Lancet, Reuters reports.
The U.S. Department of Health and Human Services (HHS) will host a Webcast to discuss how pregnant women and new mothers can prepare for the H1N1 flu on Thursday, August 27th.
A new medrxiv* preprint shows how important equitable and widespread vaccination is in preventing a resurgence of cases and deaths once restrictions on social interactions are lifted.
Terry Strom, MD, Co-director of the Transplant Institute at Beth Israel Deaconess Medical Center and a leader in the field of immune tolerance research, was awarded the 2011 Alfred Newton Richards Award from the International Society of Nephrology during a program held earlier this month as part of the World Congress of Nephrology 2011 in Vancouver, Canada.
Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced today that the independent Data Safety Monitoring Board ("DSMB") recommended that QPI-1002 (I5NP) continue on to the next phase of clinical testing.
› Verified 4 days ago